Astrazeneca Terminates License Agreement With Map Pharmaceuticals
Published: 09-Jul-2009
UDB trial failed to meet its primary endpoints
AstraZeneca has terminated the license agreement with MAP Pharmaceuticals, regarding Unit Dose Budesonide (UDB).
UDB, an investigational treatment for paediatric asthma, was the subject of an initial phase-III clinical trial conducted by MAP Pharmaceuticals. On February 23, 2009, MAP announced that the trial failed to meet its primary endpoints.
In light of the clinical trial results, AstraZeneca exercised its right to terminate the license agreement and expects to record an impairment charge of $44 million in the second quarter results.
AstraZeneca is engaged in the research, development, manufacturing and marketing of prescription medicines and supplier for healthcare services. It is focused in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.
MAP Pharmaceuticals is dedicated to developing and commercialising new therapies for children and adults suffering from chronic conditions.
Network Sites

Suppliers To This Sector
Browse A-Z
Solutions4Science
Temperature Mapping and Validation Services ...
Exploristics
Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...
NeuroProof
Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...
DASGIP
Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...
BioKinetic Europe
Phase I/II Contract Research Organisation ...
Toxikon Europe
CRO Providing Preclinical Safety Studies for the Life Science Community ...
White Papers
Browse A-Z
GRACO's New FDA Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New Hydra-Clean
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New 1590 & 3150 Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Customer Testimonial – Astra Zeneca
From the control room to the downstream processing area and with an eye on utilities servi ...
Hygienic Processing
From the control room to the downstream processing area and with an eye on utilities servi ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully